目的:探讨新型糖原磷酸化酶抑制剂山楂酸(MA)对高血糖大鼠脑缺血/再灌损伤的作用。方法:通过高脂饮食(HFD)合并低剂量链脲佐菌素(STZ)注射,制作II型糖尿病大鼠模型。不同剂量MA(10,5和2.5mg·kg?1·d?1)灌胃2周。双侧颈总结扎诱导建立大鼠脑缺血模型,评价MA对脑缺血/再灌II型糖尿病大鼠神经保护作用。结果:MA可显著降低II型糖尿病大鼠的空腹血糖(GLU)、血浆甘油三酯(TG)和总胆固醇(TC)水平。脑缺血II型糖尿病大鼠脑组织中丙二醛(MDA)含量显著增高,超氧化物歧化酶(SOD)活性显著下降;缺血3d后海马CA1区可观察到显著神经元损伤。MA显著减轻脑缺血损伤,并呈剂量依赖性。此外,MA可显著降低皮层和海马区MDA含量,减轻脑组织的脂质过氧化反应,提高缺血再灌大鼠脑组织的SOD活性。结论:MA预作用对II型糖尿病合并脑缺血诱导的损伤具有良好的保护作用。
AIM:To investigate the effects of maslinic acid(MA),a novel glycogen phosphorylase inhibitor in hyperglycemic rats after cerebral ischemia/reperfusion injury.METHODS:Rats were fed with high fat diet(HFD) followed by low-dose streptozotocin(STZ) injection to induce metabolic syndrome.Three doses of MA(10,5 and 2.5 mg·kg?1·d?1) were administered once daily by i.g.for 2 weeks.Neurological outcomes were compared in vehicle and MA treated HFD/STZ rats with cerebral ischemia/reperfusion injury induced by bilateral common carotid artery occlusion.RESULTS:The elevation of plasma fasting glucose(GLU),serum plasma triglyceride(TG) and plasma total cholesterol(TC) was antagonized by MA significantly.Cerebral ischemia with pre-existing hyperglycemia and hyperlipemia caused prominent elevation in MDA levels and decrease in SOD activity.Extensive neuronal death occurred in the CA1 area of hippocampus at day 3 after forebrain ischemia.MA significantly attenuated ischemia-induced neuronal death in a dose-dependent manner.Moreover,MA caused a significant reduction in MDA levels and elevation in SOD activity in both cortex and hippocampus.CONCLUSION:Results suggested the prophylaxis of MA may also show beneficial effects in reducing cerebral damage after stroke for patients with type 2 diabetes.